Initiative for Medicines, Access & Knowledge
@imakglobal.bsky.social
We are a team of lawyers, scientists, and health experts challenging systemic injustice and advocating for health equity in drug development and access.
SENATOR WELCH: Pharmaceutical companies used to be run by scientists. They’re now run by MBAs.
December 4, 2025 at 2:52 PM
SENATOR WELCH: Pharmaceutical companies used to be run by scientists. They’re now run by MBAs.
During our recent webinar, @tahiramin.bsky.social, @welch.senate.gov, and @emilypisacreta.bsky.social looked back at a 2019 exchange between Sen. John Cornyn and former AbbVie CEO Richard Gonzalez, in which Gonzalez openly admitted to stockpiling hundreds of patents on Humira.
December 3, 2025 at 11:19 PM
During our recent webinar, @tahiramin.bsky.social, @welch.senate.gov, and @emilypisacreta.bsky.social looked back at a 2019 exchange between Sen. John Cornyn and former AbbVie CEO Richard Gonzalez, in which Gonzalez openly admitted to stockpiling hundreds of patents on Humira.
Sen. @hassan.senate.gov (D-NH): What are the real impacts of these patent games on patients?
Dr. @wbfeldman.bsky.social: These patent games can delay generic and biosimilar competition, which keep prices high...patients can’t afford their medications and we see worse clinical outcomes.
Dr. @wbfeldman.bsky.social: These patent games can delay generic and biosimilar competition, which keep prices high...patients can’t afford their medications and we see worse clinical outcomes.
October 27, 2025 at 11:09 PM
Sen. @hassan.senate.gov (D-NH): What are the real impacts of these patent games on patients?
Dr. @wbfeldman.bsky.social: These patent games can delay generic and biosimilar competition, which keep prices high...patients can’t afford their medications and we see worse clinical outcomes.
Dr. @wbfeldman.bsky.social: These patent games can delay generic and biosimilar competition, which keep prices high...patients can’t afford their medications and we see worse clinical outcomes.
Senator Susan Collins (R-ME) took time during a recent hearing on 340B reform to highlight the importance of patent reform.
October 27, 2025 at 11:05 PM
Senator Susan Collins (R-ME) took time during a recent hearing on 340B reform to highlight the importance of patent reform.
Watch the full exchange here👇
October 27, 2025 at 11:04 PM
Watch the full exchange here👇
Last week, the Senate HELP Committee held a hearing on 340B reform. During the hearing, Sen. Hawley (R-MO) asked @wbfeldman.bsky.social how we can lower drug prices for Americans. Dr. Feldman outlined several steps we can take while making clear that patent reform is critical.
October 27, 2025 at 11:04 PM
Last week, the Senate HELP Committee held a hearing on 340B reform. During the hearing, Sen. Hawley (R-MO) asked @wbfeldman.bsky.social how we can lower drug prices for Americans. Dr. Feldman outlined several steps we can take while making clear that patent reform is critical.